Michael Gutch Entasis Therapeutics Holdings Inc. (ETTX) insider trading activity

ETTX Quotes by TradingView

Michael Gutch is Officer of Entasis Therapeutics Holdings Inc.. Currently has a direct ownership of 167,572 shares of ETTX, which is worth approximately $0. The most recent transaction as insider was on Jan 18, 2022, when has been sold 125,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K
0% 3M change
0% 12M change
Total Value Held $0

Michael Gutch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 18 2022
BUY
Grant, award, or other acquisition
-
125,000 Added 42.72%
167,572 Common Stock
Nov 02 2021
SELL
Payment of exercise price or tax liability
$10,787 $2.94 p/Share
3,669 Reduced 7.93%
42,572 Common Stock
Oct 19 2021
SELL
Open market or private sale
$11,991 $3.19 p/Share
3,759 Reduced 7.52%
46,241 Common Stock
Oct 19 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 33.33%
50,000 Common Stock
Jan 15 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 50.0%
25,000 Common Stock

Also insider at

ALBO
ALBIREO PHARMA, INC. Healthcare
Director
MG

Michael Gutch

Officer
Waltham, MA

Track Institutional and Insider Activities on ETTX

Follow Entasis Therapeutics Holdings Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETTX shares.

Notify only if

Insider Trading

Get notified when an Entasis Therapeutics Holdings Inc. insider buys or sells ETTX shares.

Notify only if

News

Receive news related to Entasis Therapeutics Holdings Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ETTX